Dr. Cohen Discusses NK-Directed Therapy in Head and Neck Cancer

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses natural killer-directed therapy in head and neck cancer.

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses natural killer (NK)-directed therapy in head and neck cancer.

Cohen says that NK cell-directed therapies can manipulate NKs ex vivo and then reinfuse them, or even create NKs from regular stem cells from the blood or skin.

Related Content:

OncLive TVHead & Neck Cancers
Dr Elder on the Initial Safety Profile of IGV-001 in Newly Diagnosed Glioblastoma
Dr Lukas on Survival Outcomes With Eflornithine in IDH-Mutant Anaplastic Astrocytoma
Dr Pant on the Importance of Targeted Therapy and Mutation Testing in Pancreatic Cancer